Comparison Between Bupivacaine-Dexmedetomidine Versus Bupivacaine-Dexamethasone in Pericapsular Nerve Group (PENG) Block

Last updated: February 28, 2024
Sponsor: Ain Shams University
Overall Status: Active - Recruiting

Phase

1

Condition

Osteoporosis

Treatment

Pericapsular Nerve Group (PENG) Block

Clinical Study ID

NCT06294665
MD113/2023
  • Ages 18-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of this work is to compare the effectiveness of bupivacaine- dexmedetomidine mixture versus bupivacaine-dexamethasone mixture in PENG Block as Post-operative Analgesia in Hip surgeries

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Age 18-65 years.
  2. Sex: Both sexes.
  3. American Society of Anaesthesiologists (ASA) Physical Status Class I and II.
  4. Scheduled for hip surgeries under spinal anaesthesia.

Exclusion

Exclusion Criteria:

  1. Declining to give written informed consent.
  2. History of allergy to the medications used in the study.
  3. Contraindications to regional anesthesia (including patient refusal, coagulopathy andlocal infection).
  4. Psychiatric disorder.
  5. American Society of Anesthesiologists (ASA) Physical Status Class III and IV.

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: Pericapsular Nerve Group (PENG) Block
Phase: 1
Study Start date:
March 01, 2024
Estimated Completion Date:
January 01, 2025

Connect with a study center

  • Ain Shams University

    Cairo, 11122
    Egypt

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.